Patents by Inventor Timothy Ratliff

Timothy Ratliff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11960803
    Abstract: Systems and methods are described for modeling and analyzing utility structures according to applied loads. Particularly, a model engine can utilize inputs related to a utility structure, environmental conditions to which the utility structure is subjected, and engineering standards expected of the utility structure, and analyze the structure's loading and performance based on analysis configuration inputs. An engine or multiple engines can be run locally, or can be instantiated in a cloud to assist with multiple or complex calculations. Hybrid and geometric non-linear analyses and outputs can be performed or provided.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: April 16, 2024
    Assignee: Bentley Systems, Incorporated
    Inventors: William Schulze, Brett Willitt, David Cain, Michael H. Ford, Kevan Kramb, Timothy G. S. Overly, Michael Ratliff, Jeremy Wentworth
  • Patent number: 9861707
    Abstract: Composition and methods are disclosed for utilizing microaggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: January 9, 2018
    Assignee: Purdue Research Foundation
    Inventors: Ruben Claudio Aguilar, Timothy Ratliff, David Thompson, Scott Crist
  • Publication number: 20170095568
    Abstract: Composition and methods are disclosed for utilizing microaggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Application
    Filed: December 12, 2016
    Publication date: April 6, 2017
    Inventors: Ruben Claudio AGUILAR, Timothy RATLIFF, David THOMPSON, Scott CRIST
  • Patent number: 9518114
    Abstract: Composition and methods are disclosed for utilizing micro-aggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Grant
    Filed: November 11, 2011
    Date of Patent: December 13, 2016
    Assignee: Purdue Research Foundation
    Inventors: Ruben Claudio Aguilar, Timothy Ratliff, David Thompson, Scott Crist
  • Publication number: 20130230584
    Abstract: Composition and methods are disclosed for utilizing micro-aggregation of FAP-containing complexes to promote their fast internalization. This approach allows the uptake of cytotoxic cargo coupled to either FAP-Antibodies or FAP-liposome complexes by tumor bladder cells. Importantly, this approach is efficient even under serum-free conditions such as the ones found in the lumen of the bladder.
    Type: Application
    Filed: November 11, 2011
    Publication date: September 5, 2013
    Applicant: PURDUE RESEARCH FOUNDATION
    Inventors: Ruben Claudio Aguilar, Timothy Ratliff, David Thompson, Scott Crist
  • Publication number: 20060018880
    Abstract: A novel immunostimulating delivery system is disclosed which provides for generation of a specific antibody response and specific T cell response to delivered antigens. According to the invention, the antigen or a nucleotide encoding the same is contained within, impregnated in or associated with a biocompatible collagen based carrier composition. Methods and compositions for practicing the same are disclosed.
    Type: Application
    Filed: January 24, 2005
    Publication date: January 26, 2006
    Applicant: University of Iowa Research Foundation
    Inventors: Timothy Ratliff, David Lubaroff, D. Siemens, Bennett Elzey
  • Patent number: 6900185
    Abstract: The present invention is directed to methods for inhibiting tumor cell growth, causing tumor regression or eliminating tumor cells in a mammal afflicted with a tumor by administering to a TRAIL-sensitive cell a vector having a DNA expression cassette containing a promoter and a DNA sequence encoding TRAIL, wherein the expression of TRAIL results in tumor inhibition, regression or elimination.
    Type: Grant
    Filed: April 12, 2000
    Date of Patent: May 31, 2005
    Assignee: University of Iowa Research Foundation
    Inventors: Thomas S. Griffith, Timothy Ratliff